Jeffry Schneider has lived in Manhattan, New York his entire lifetime. He is well known for his involvement with Ascendant Capital LLC. Some of the skills that he has managed to acquire over time include investments, hedge funds, and alternative investments. Jeffry Schneider has been shaped by his educational background and innovative mind. For his first degree, he attended the University of Massachusetts at Amherst. He has been blessed with knowledge when it comes to alternative investments strategies and ability to establish a good relationship with clients and fellow work-mates.
Soon after graduating from the University, he established a company called Axiom Capital Management. He has also founded other companies like paradigm and alternative investments. It’s at Paradigm that he learned the art of analyzing managers. This proved to be a valuable asset in his life. At Ascendant Capital, Jeffry specializes with private equity, real estate, and hedge funds. Some of the clients that company deals with include international markets, private banks, and registered investment advisors. Jeffry has been involved with charitable causes such as the Gazelle Foundation and the Wonders and Worries Foundation.
Before founding the mentioned companies, Jeffry Schneider was involved with other companies as an employee that include Alex Brown, Merrill Lynch, and Smith Barney. Some of the things he enjoys to do on his free time include staying fit and healthy eating. He has participated in a number of marathons around the world. Jeffry loves to travel as he has traveled the world with destinations in Europe, Africa, Asia and South America. Under the leadership of Jeffry Schneider, Ascendant Capital has recorded unprecedented growth and success. The company managed to grow into a 30 employee firm from two employees. Over these years, he has managed to collect over $1 billion for hedge fund managers. The company deals with over 50 broker dealers as well as more than 250 investment advisors.
Since the beginning of 2016, the company has developed a strategy of raising over $ 50 million each month. With his continued commitment to offering exceptional services, Ascendant Capital seems to be heading in the right direction under his leadership.
Oncotarget is a multidisciplinary conventional journal. Oncotarget has free access. It publishes papers online every week. Every article or issue can be printed on special demand. The ultimate purpose of Oncotarget is to avail scientific results widely in a fast manner and to enable quick sharing of exceptional discoveries. Oncotarget also seeks to connect different biomedical science fields and to foster applications of clinical and basic science to battle disease.
Oncotarget is led by the most prominent scientists and assists all researchers in contributing to science progress. The mission of the company is to see a life without disease. Oncotarget has grown and expanded to become a successful journal since its inception in 2010. Oncotarget decided to launch sections other than oncology due to this success.
According to Research Gate, the word “Oncotarget” covers all pathways, molecules, and cellular functions popular in aging and cancer, atherosclerosis, neurodegeneration, neurons, lymphocytes, microbes, and cancer cells. The Editors-in-chief of Oncotarget are Mikhail V. Blagosklonny and Andrei V. Gudkov. Both of them are scientists at the Roswell Park Cancer Institute, Buffalo, NY.
Two members who serve in Oncotarget’s Editorial Board by the names Gregg L. Semenza and William G. Kaelin were awarded the Lasker Award for their contributions to the discovery of the Oxygen-sensing Pathway in 2016. This came as a big honor for Oncotarget. Oncotarget has been able to publish more than 370 papers on topics that are related to oxygen since 2010.
The Editorial Board at Oncotarget is made up of experienced and qualified scientists who share the goal of the journal to eliminate the disease. They all work at different health and medical institutions. Some of the sections that are getting introduced by Oncotarget include:
- Microbiology & Immunology
- Aging/ Gerotarget
- All areas of Pharmacology
- Cell and Mol Biology
Oncotarget has played a significant role in eliminating the disease by availing scientific results to all its readers. The journal encourages all scientific researchers to send their articles on the subject of Oncotarget and the newly launched sections. The journal has gained a huge following with people all over the world following every single issue published.
Anthony Petrello is the Chairman of one of the world’s largest oil drilling companies, Nabors Industries where he has spent 25 years in managing their operations and overseeing investment strategies and investor relations. Nabors has developed advanced drilling technologies from horizontal wells to modular offshore rigs, and even their Super ChemDAT system. Petrello certainly has done well in finding solutions and guiding the company even through a highly volatile oil industry, but he has even more skills in solving problems that he’s brought through the years from his days in college and as a lawyer.
His childhood wasn’t too different than most of his neighborhood acquaintances, but he did have a love of solving math problems during some of his spare time. His high academic achievements helped him get accepted to Yale University where he became a favorite student of Professor Serge Lang, one of the most famous mathematicians of his time. Petrello graduated with both a bachelor’s and a master’s in mathematics, but opted instead to pursue a career in practicing law. After getting his J.D. form Harvard, he joined Baker & McKenzie law firm in 1979. After 13 years in corporate law practice including becoming the firm’s Managing Partner in 1986, Petrello joined Nabors Industries as Chief Operating Officer and later became Chairman in 2011.
He’s married to Cynthia Petrello, formerly Carrafa and has a young daughter named Carena who he loves very much. Carena had a form of leukemia not long after she was born that had to be treated fast, and while the cancer was eliminated she suffered damage that caused Cerebral Palsy. It was a difficult time in Anthony Petrello’s life and he wanted to do everything he could to provide care and find treatment options for Carena. When he was informed that there was nothing that could be done currently, he began to pledge gifts to institutions for research into neurological diseases and joined the Board of Trustees at the Texas Children’s Hospital. He also became friends with Jan and Dan Duncan who have helped bring attention to neurological diseases through fundraising and starting the Dan and Jan Duncan Institute for Neurological Research at TCH.